SynBiotic SE (SBX.DE)

EUR 4.6

(-3.97%)

Net Income Summary of SynBiotic SE

  • SynBiotic SE's latest annual net income in 2023 was -10.63 Million EUR , up 56.36% from previous year.
  • SynBiotic SE's latest quarterly net income in 2023 FY was -10.63 Million EUR , up 56.36% from previous quarter.
  • SynBiotic SE reported an annual net income of -24.36 Million EUR in 2022, down -86.4% from previous year.
  • SynBiotic SE reported an annual net income of -13.06 Million EUR in 2021, down -1384.53% from previous year.
  • SynBiotic SE reported a quarterly net income of - EUR for 2023 Q2, down 0.0% from previous quarter.
  • SynBiotic SE reported a quarterly net income of -1.28 Million EUR for 2022 Q2, down 0.0% from previous quarter.

Annual Net Income Chart of SynBiotic SE (2023 - 2018)

Historical Annual Net Income of SynBiotic SE (2023 - 2018)

Year Net Income Net Income Growth
2023 -10.63 Million EUR 56.36%
2022 -24.36 Million EUR -86.4%
2021 -13.06 Million EUR -1384.53%
2020 -880.38 Thousand EUR -6455.88%
2019 -13.42 Thousand EUR -1533.7%
2018 -822.00 EUR 0.0%

Peer Net Income Comparison of SynBiotic SE

Name Net Income Net Income Difference
MPH Health Care AG 29.54 Million EUR 135.982%
Apontis Pharma AG -11.3 Million EUR 5.949%
Dermapharm Holding SE 62.36 Million EUR 117.045%
Evotec SE -83.91 Million EUR 87.331%
MERCK Kommanditgesellschaft auf Aktien 2.82 Billion EUR 100.376%
PharmaSGP Holding SE 16.39 Million EUR 164.833%